- Forums
- ASX - By Stock
- TIS
- a proper update
a proper update , page-26
-
Share
As you are aware, vitrogro will not diminish the need for pressure bandages, it will supplement them as part of the treatment plan. Maybe there are some lesser used treatments that will diminish but, in the main, there is no great fear of significant loss of business by the current market players, who are unlikely to alter their recommended treatment plans for new patients.
The question remains. COMMERCIALLY SPEAKING, why is this of value to the "partners"? Why would they wish to pay $millions and millions for a small percentage increase?
Now some have replied "competition will do it ... competitiors blah blah"
What a load of rubbish. The competitors have already given you their reply. They showed TIS the door.
The market players' position to date was pretty straightforward. They are not convinced TIS has as yet anything of benefit to offer them commercially or strategically, and they do not fear the commercial consequence of their competitor getting the product ........ otherwise TIS would have a deal.
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Is oil undervalued?